Skip to content

John L Lamattina, Director at Ligand Pharmaceuticals, sold LGND on Jun 10, 2026

Data as of Oct 16

▼ SELL$63.5K257 shares at $247.22John L Lamattina DirectorLGND Ligand Pharmaceuticals Inc
Watch LGND
Traded
Jun 10, 2026
Disclosed
Jun 12, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

John L Lamattina, Director at Ligand Pharmaceuticals, sold LGND on Jun 10, 2026TRADEDDISCLOSED
LGNDSimilar stocks (XLV — its sector index fund), rebased to LGND's price on the disclosure day
LGND since disclosure
+15.7%
after the sale
Similar stocks (XLV) since disclosure
+14.9%
XLV — its sector index fund

Change in closing price from Jun 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJohn L Lamattina DirectorLGND Ligand Pharmaceuticals Inc$857Kdisclosed Jun 12 · filed 2 days after the trade
  2. ▼ SELLJohn L Lamattina DirectorLGND Ligand Pharmaceuticals Inc$174Kdisclosed Jun 12 · filed 2 days after the trade
  3. ▼ SELLJohn L Lamattina DirectorLGND Ligand Pharmaceuticals Inc$57.6Kdisclosed Jun 12 · filed 2 days after the trade

See every trade on LGND →